Related Articles
Capecitabine‑induced hand‑foot syndrome does not emerge in the complex regional pain syndrome‑affected limb: A case report
Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature
Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand‑foot syndrome: A meta‑analysis
A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment
Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophylaxis is performed continuously